Newmed Energy Limited Partnership (DKDRF)
OTHER OTC:DKDRF
DKDRF Stock Chart & Stats
$6.10
-$0.01(-0.30%)
At close: 4:00 PM EST
$6.10
-$0.01(-0.30%)
Day’s Range― - ―
52-Week Range$3.75 - $7.55
Previous CloseN/A
Volume121.00
Average Volume (3M)472.00
Market Cap
$6.71B
Enterprise Value$8.66B
Total Cash (Recent Filing)$213.40M
Total Debt (Recent Filing)$1.53B
Price to Earnings (P/E)29.9
Beta0.41
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.47%
Share Statistics
EPS (TTM)0.19
Shares Outstanding1,173,814,700
10 Day Avg. Volume152
30 Day Avg. Volume472
Financial Highlights & Ratios
PEG Ratio-0.62
Price to Book (P/B)3.51
Price to Sales (P/S)7.08
P/FCF Ratio21.80
Enterprise Value/Market Cap1.29
Enterprise Value/Revenue10.10
Enterprise Value/Gross Profit23.53
Enterprise Value/Ebitda13.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)$3.57M
Bulls Say, Bears Say
Bulls Say
High Profitability MarginsVery high TTM gross (~55%) and net (~35%) margins indicate structural cost advantages or favorable contract pricing. Durable margins support operating profitability, provide a buffer versus commodity swings, and underpin the capacity to fund capex, exploration and partner distributions over coming quarters.
Solid Cash GenerationOperating cash flow (~494M TTM) and positive free cash flow (~223M TTM) show the business converts earnings into cash at scale. OCF materially exceeds net income (~2.5x), enabling reinvestment, debt paydown and distributions while providing financial flexibility through commodity-cycle variability.
Improved Leverage / Balance-sheet QualityLeverage has materially improved to debt-to-equity ~0.59x with equity expansion and healthy ROE (~18%), lowering refinancing and solvency risk. A stronger balance sheet increases capacity to fund development, pursue export or midstream projects, and better absorb episodic earnings shocks.
Bears Say
Revenue Decline / Choppy Top LineA ~-12.6% TTM revenue decline and a choppy top-line across recent years signal volume or pricing headwinds. Prolonged top-line weakness reduces scale benefits, constrains reinvestment for reserves development or exports, and forces greater reliance on margin preservation to sustain earnings.
Weakening Free Cash Flow TrendFCF declining ~-20% TTM and representing only ~55% of net income suggests heavier reinvestment needs or working-capital swings. A weakening FCF trend limits surplus for debt reduction, discretionary capex, and distributions, increasing the firm's sensitivity to further earnings or commodity price deterioration.
Earnings Volatility And Higher Absolute DebtDespite improved leverage ratios, absolute debt rose in the TTM versus 2025 and the partnership is exposed to earnings volatility inherent to E&P. In a cyclical commodity environment, higher nominal debt plus volatile cash flows can quickly pressure leverage and elevate refinancing and liquidity risk.
Newmed Energ Pu News
DKDRF FAQ
What was Newmed Energy Limited Partnership’s price range in the past 12 months?
Newmed Energy Limited Partnership lowest stock price was $3.75 and its highest was $7.55 in the past 12 months.
What is Newmed Energy Limited Partnership’s market cap?
Newmed Energy Limited Partnership’s market cap is $6.71B.
When is Newmed Energy Limited Partnership’s upcoming earnings report date?
Newmed Energy Limited Partnership’s upcoming earnings report date is Aug 06, 2026 which is in 55 days.
How were Newmed Energy Limited Partnership’s earnings last quarter?
Newmed Energy Limited Partnership released its earnings results on May 19, 2026. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Newmed Energy Limited Partnership overvalued?
According to Wall Street analysts Newmed Energy Limited Partnership’s price is currently Overvalued.
Does Newmed Energy Limited Partnership pay dividends?
Newmed Energy Limited Partnership pays a Quarterly dividend of $0.051 which represents an annual dividend yield of 3.47%. See more information on Newmed Energy Limited Partnership dividends here
What is Newmed Energy Limited Partnership’s EPS estimate?
Newmed Energy Limited Partnership’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Newmed Energy Limited Partnership have?
Newmed Energy Limited Partnership has 1,173,814,700 shares outstanding.
What happened to Newmed Energy Limited Partnership’s price movement after its last earnings report?
Newmed Energy Limited Partnership reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 2.421%.
Which hedge fund is a major shareholder of Newmed Energy Limited Partnership?
Currently, no hedge funds are holding shares in DKDRF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Newmed Energy Limited Partnership
NewMed Energy - Limited Partnership is an energy firm engaged in the exploration, development, production, and commercialization of petroleum, natural gas, and condensate, primarily operating in Israel and Cyprus. The company holds significant interests in several key offshore endeavors, including Israel's Leviathan project (500 km², situated west of Haifa's coast), the Yam Tethys project (500 km², west of Ashkelon's coast), and the Tanin and Karish leases (500 km², west of Nahariya's coast). Its portfolio also extends to Block 12 in Cyprus (approximately 386 km²) and the substantial Boujdour Atlantique exploration license (around 33,812 km²) located in the southern Moroccan exclusive economic zone. NewMed Energy supplies natural gas to various clients, such as independent power producers, marketing companies, and industrial consumers, and exports natural gas to Jordan and Egypt. NewMed Energy Management Ltd. functions as the company's general partner. Originally incorporated in Herzliya, Israel, in 1993, the company was formerly known as Delek Drilling - Limited Partnership before adopting its current name in February 2022. It operates as a subsidiary of Delek Energy Systems Ltd.
DKDRF Company Deck
DKDRF Earnings Call
Q1 2026
0:00 / 0:00
Technical Analysis
Ownership Overview
―
Insiders
0.09% Mutual Funds
― Other Institutional Investors
96.85% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---